GeoVax Labs Depreciation & Amortization 2011-2026 | GOVX

Annual Depreciation & Amortization GeoVax Labs

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
74.2 K	56.3 K	38.5 K	19.7 K	8.35 K	19.8 K	28 K	28.8 K	28.9 K	69 K	78.9 K	93.6 K	109 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
109 K	8.35 K	50.2 K

Quarterly Depreciation & Amortization GeoVax Labs

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	16.9 K	-	-	-	19.6 K	-	-	-	17.3 K	-	42.2 K	-	12.3 K	-	26.8 K	-	4.52 K	-	2.98 K	7.03 K	994	-	5.69 K	3.8 K	1.9 K	-	14.9 K	9.93 K	4.98 K	-	20.7 K	13.8 K	6.9 K	-	21.6 K	14.4 K	7.2 K	-	21.7 K	14.5 K	7.23 K	-	50 K	32.7 K	16.4 K	-	52.7 K	35.1 K	17.6 K	-	70.2 K	46.8 K	23.4 K	-	81.3 K	54.2 K	27.1 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
81.3 K	994	22.4 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	18.4 M	$ 3.44	-4.32 %	$ 1.03 B	Canada
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
ADMA Biologics ADMA	8 M	$ 15.36	-2.17 %	$ 3.66 B	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Apellis Pharmaceuticals APLS	1.56 M	$ 20.28	0.65 %	$ 2.56 B	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.79	-1.15 %	$ 4.31 M	China
Autolus Therapeutics plc AUTL	7.55 M	$ 1.51	1.35 %	$ 385 M	Britain
China SXT Pharmaceuticals SXTC	82.3 K	$ 2.01	-1.36 %	$ 2.86 M	China
Galmed Pharmaceuticals Ltd. GLMD	42 K	$ 0.67	7.08 %	$ 624 K	Israel
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Anika Therapeutics ANIK	6.43 M	$ 14.05	-1.44 %	$ 206 M	USA
ANI Pharmaceuticals ANIP	67.7 M	$ 74.36	-1.64 %	$ 1.44 B	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	67 K	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	503 K	$ 162.43	0.6 %	$ 8.08 B	USA
BioCryst Pharmaceuticals BCRX	1.25 M	$ 8.49	-0.18 %	$ 1.75 B	USA
BridgeBio Pharma BBIO	5.43 M	$ 65.66	-0.78 %	$ 12.6 B	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Brainstorm Cell Therapeutics BCLI	240 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
BioMarin Pharmaceutical BMRN	79.6 M	$ 61.3	1.21 %	$ 11.8 B	USA
CymaBay Therapeutics CBAY	681 K	-	-	$ 3.45 B	USA